| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Bausch Health Companies Inc. (BHC) have been net sellers, shedding 36,827 shares worth roughly $259K on balance.
Classified under Pharmaceuticals (Health Care sector), BHC's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 73.26M | $457.85M | - | |
| CEO | 2.32M | $13.78M | - | |
| CFO | 706.5K | $4.19M | - | |
| VP | 616.8K | $3.56M | - | |
| Dir | 441.0K | $2.57M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Paulson John52 | Director | Buy | 2,788,608 | $5.27 | $14,700,256.94 | +10.5% | +29.8% | - | |
| Dec 2, 2024 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 440 | $8.35 | $3,674.00 | -0.1% | -8.3% | -11.8% | |
| Sep 6, 2024 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 13,370 | $6.21 | $83,027.70 | -3.0% | +30.8% | +18.4% | |
| Mar 4, 2024 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 6,313 | $9.80 | $61,867.40 | -1.2% | -33.9% | -26.8% | |
| Dec 5, 2023 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 220 | $7.38 | $1,623.60 | - | +34.4% | +14.0% | |
| Nov 6, 2023 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 43 | $7.61 | $327.23 | - | +4.3% | +30.1% | |
| Sep 6, 2023 | Carson Seana60 | EVP, General Counsel | Sell10b5-1 | 6,685 | $8.28 | $55,351.80 | -1.7% | -14.7% | -26.0% | |
| Feb 28, 2023 | Carson Seana60 | EVP, General Counsel | Sell | 292 | $9.32 | $2,721.44 | - | -12.0% | -1.2% | |
| Apr 14, 2022 | Spurr Robert82 | U.s. President-pharma Business | Sell | 1,595 | $22.19 | $35,393.05 | -1.7% | -59.4% | -66.2% | |
| Mar 15, 2022 | Spurr Robert82 | U.s. President-pharma Business | Sell | 4,846 | $22.20 | $107,581.20 | -5.0% | -65.5% | -65.3% |